
Formatting Annotated Case Report Forms (aCRFs): Part 1 Blog Post
Discover essential tips for formatting aCRFs with clarity and regulatory compliance in mind. Read the first blog in this series…
Discover essential tips for formatting aCRFs with clarity and regulatory compliance in mind. Read the first blog in this series…
In this webinar, Amy Garrett reviews published guidance from regulatory agencies and provides best practices for CRF annotations.
The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical trials, especially in Alzheimer’s disease. These long‐duration trials involve many stakeholders, especially the patients and…
3 key tips to set your pediatric program up for success with the RACE for Children Act by Lynne Georgopoulos, RN, MSHS, RAC, Vice President, Regulatory Strategy at Certara On…
In this blog, we clarify the meaning & purpose of the duplicate records validation rules, then answer some FAQs about duplicate records.
By leveraging quantitative models, regulatory expertise, and real-world data, we empower our partners to fast-track innovative therapies while meeting stringent regulatory standards.
Certara’s Pediatric MIDD Accelerator advances efficient and reliable pediatric drug development processes that optimize dosing and get critical medicines to children faster.